• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[The effects of ethinyl estradiol on glucose metabolism in postmenopausal women].

作者信息

Wu J, Bi Y, Wang H

机构信息

Drum Tower Hospital of Nanjing.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 1997 Sep;32(9):528-31.

PMID:9639751
Abstract

OBJECTIVE

To study the effects of ethinyl estradiol on glucose metabolism in postmenopausal women.

METHODS

Postmenopausal women were randomized as nine cases (group A) receiving 0.025 mg ethinyl estradiol (EE) and ten cases (group B) receiving EE 0.05 mg for three months. The oral glucose tolerance test (OGTT) and frequently sampled intravenous glucose tolerance test (FSIGT) were performed before and after EE respectively. The levels of plasma glucose, insulin were measured and the area under curve (AUC) and insulin sensitivity indexes (SI) were calculated.

RESULTS

Both two dosages of EE administration effectively decreased the levels of fasting plasma glucose and insulin and significantly reduced the AUC of insulin. SI was increased significantly. There were no significant differences in AUC of glucose before and after treatment in group A, but in group B the AUC of glucose significantly increased after treatment.

CONCLUSIONS

EE may significantly reduce the levels of fasting plasma glucose and insulin concentrations and abate the insulin resistance in postmenopausal women; 0.05 mg EE possibly causes the deterioration in glucose tolerance, suggesting the use of 0.025 mg EE as an appropriate dosage.

摘要

相似文献

1
[The effects of ethinyl estradiol on glucose metabolism in postmenopausal women].
Zhonghua Fu Chan Ke Za Zhi. 1997 Sep;32(9):528-31.
2
Insulin resistance and hypertension in postmenopausal women.绝经后女性的胰岛素抵抗与高血压
J Hum Hypertens. 2002 Mar;16 Suppl 1:S145-50. doi: 10.1038/sj.jhh.1001362.
3
Effect of hormone therapy on the enteroinsular axis.激素疗法对肠胰岛轴的影响。
Menopause. 2005 Sep-Oct;12(5):630-638. doi: 10.1097/01.gme.0000172266.47820.43.
4
A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel.一项为期1年的随机研究,旨在评估口服避孕药剂量降低对脂质和碳水化合物代谢的影响:20微克炔雌醇与100微克左炔诺孕酮联合使用。
Contraception. 2005 Feb;71(2):111-7. doi: 10.1016/j.contraception.2004.08.017.
5
Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.中国大规模多囊卵巢综合征女性临床特征分析
Neuro Endocrinol Lett. 2007 Dec;28(6):807-10.
6
Rosiglitazone and ethinyl estradiol/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance.罗格列酮与乙炔雌二醇/醋酸环丙孕酮单药及联合治疗超重多囊卵巢综合征伴胰岛素抵抗的女性。
Hum Reprod. 2006 Jan;21(1):121-8. doi: 10.1093/humrep/dei312. Epub 2005 Sep 30.
7
Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.含醋酸氯地孕酮或去氧孕烯口服避孕药对胰岛素敏感性和脂质代谢的影响:一项随机试验。
Contraception. 2009 Feb;79(2):111-6. doi: 10.1016/j.contraception.2008.09.002. Epub 2008 Oct 16.
8
Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose.基于负荷后血浆葡萄糖与空腹血浆葡萄糖之间的关系预测2型糖尿病进展的风险。
Diabetes Care. 2006 Jul;29(7):1613-8. doi: 10.2337/dc05-1711.
9
Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study.纳曲酮在胰岛素分泌过度的绝经后女性中的应用:一项试点研究。
Fertil Steril. 2004 Apr;81(4):1047-54. doi: 10.1016/j.fertnstert.2003.05.036.
10
Insulin sensitivity during postmenopausal hormone replacement with transdermal estradiol and intrauterine levonorgestrel.
Acta Obstet Gynecol Scand. 1999 Jul;78(6):540-5.